A notable number of these studies, 44% (10/23), were centered on rare blood‐related cancers identified by distinctive genetic markers, such as FLT3+ in acute myeloid leukemia and the Philadelphia chromosome in acute lymphoblastic leukemia.34, 35, 39, 43, 45, 48, 49, 50, 52, 53. Here, FLT3 is linked to acute lymphoblastic leukemia.